Answers are grounded in this paper and cite their sources.
Identifies protopanaxadiol from ginseng as an effective SARS-CoV-2 inhibitor, suggesting new antiviral strategies.
COVID-19 remains a global health concern, yet current antivirals are restricted to high-risk patients and face issues of resistance. To establish a safer evaluation system, we constructed a noninfectious SARS-CoV-2 replicon using a BAC vector driven by the CMV promoter. Among the tested cell lines, HuH-7.6c supported the most efficient replication. Replication was inhibited by remdesivir, nirmatrelvir, and molnupiravir, but not by favipiravir or AT-527. A screening of 373 food-derived compounds identified (20R)-protopanaxadiol (PPD), a ginseng metabolite, as a novel inhibitor. Together, this work highlights this BAC-vectored replicon as a practical platform for antiviral screening and identifies the potential of safe, food-derived supplements in combating SARS-CoV-2.
No takes yet. Share an insight, caveat, or question.
Takeda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: